Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Shilpa-Medicare

More Like This

PR Newswire associated0

Shilpa Medicare Makes History: First Indian Company Completes Phase 1 Trial for Recombinant Human Albumin (rHA) 20%

PR Newswire associated0

Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH

PR Newswire associated0

Airway Therapeutics Receives European Medicines Agency Pediatric Committee Approval for Zelpultide Alfa's Study Plan in Bronchopulmonary Dysplasia for Very Preterm Infants

PR Newswire associated0

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States

PR Newswire associated0

BMC Showcases Latest Sleep and Respiratory Healthcare Solutions at MEDICA 2024

Chiesi and Gossamer Bio Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in Pulmonary Arterial Hypertension and Other Respiratory Indications

Phillips Medisize Announces Scientific Presentations and Engagements at Respiratory Drug Delivery Conference, Highlighting Its Expanded Inhalation Drug Delivery Capabilities

Dr. Abdulkader Rahmo

SMSbiotech Initiates Groundbreaking Phase 1 Human Clinical Trial for COPD